Cargando…

Use of dynamic contrast-enhanced MRI to measure subtle blood–brain barrier abnormalities()

There is growing interest in investigating the role of subtle changes in blood–brain barrier (BBB) function in common neurological disorders and the possible use of imaging techniques to assess these abnormalities. Some studies have used dynamic contrast-enhanced MR imaging (DCE-MRI) and these have...

Descripción completa

Detalles Bibliográficos
Autores principales: Armitage, Paul A., Farrall, Andrew J., Carpenter, Trevor K., Doubal, Fergus N., Wardlaw, Joanna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025605/
https://www.ncbi.nlm.nih.gov/pubmed/21030178
http://dx.doi.org/10.1016/j.mri.2010.09.002
_version_ 1782316793549815808
author Armitage, Paul A.
Farrall, Andrew J.
Carpenter, Trevor K.
Doubal, Fergus N.
Wardlaw, Joanna M.
author_facet Armitage, Paul A.
Farrall, Andrew J.
Carpenter, Trevor K.
Doubal, Fergus N.
Wardlaw, Joanna M.
author_sort Armitage, Paul A.
collection PubMed
description There is growing interest in investigating the role of subtle changes in blood–brain barrier (BBB) function in common neurological disorders and the possible use of imaging techniques to assess these abnormalities. Some studies have used dynamic contrast-enhanced MR imaging (DCE-MRI) and these have demonstrated much smaller signal changes than obtained from more traditional applications of the technique, such as in intracranial tumors and multiple sclerosis. In this work, preliminary results are presented from a DCE-MRI study of patients with mild stroke classified according to the extent of visible underlying white matter abnormalities. These data are used to estimate typical signal enhancement profiles in different tissue types and by degrees of white matter abnormality. The effect of scanner noise, drift and different intrinsic tissue properties on signal enhancement data is also investigated and the likely implications for interpreting the enhancement profiles are discussed. No significant differences in average signal enhancement or contrast agent concentration were observed between patients with different degrees of white matter abnormality, although there was a trend towards greater signal enhancement with more abnormal white matter. Furthermore, the results suggest that many of the factors considered introduce uncertainty of a similar magnitude to expected effect sizes, making it unclear whether differences in signal enhancement are truly reflective of an underlying BBB abnormality or due to an unrelated effect. As the ultimate aim is to achieve a reliable quantification of BBB function in subtle disorders, this study highlights the factors which may influence signal enhancement and suggests that further work is required to address the challenging problems of quantifying contrast agent concentration in healthy and diseased living human tissue and of establishing a suitable model to enable quantification of relevant physiological parameters. Meanwhile, it is essential that future studies use an appropriate control group to minimize these influences.
format Online
Article
Text
id pubmed-4025605
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-40256052014-05-30 Use of dynamic contrast-enhanced MRI to measure subtle blood–brain barrier abnormalities() Armitage, Paul A. Farrall, Andrew J. Carpenter, Trevor K. Doubal, Fergus N. Wardlaw, Joanna M. Magn Reson Imaging Original Contribution There is growing interest in investigating the role of subtle changes in blood–brain barrier (BBB) function in common neurological disorders and the possible use of imaging techniques to assess these abnormalities. Some studies have used dynamic contrast-enhanced MR imaging (DCE-MRI) and these have demonstrated much smaller signal changes than obtained from more traditional applications of the technique, such as in intracranial tumors and multiple sclerosis. In this work, preliminary results are presented from a DCE-MRI study of patients with mild stroke classified according to the extent of visible underlying white matter abnormalities. These data are used to estimate typical signal enhancement profiles in different tissue types and by degrees of white matter abnormality. The effect of scanner noise, drift and different intrinsic tissue properties on signal enhancement data is also investigated and the likely implications for interpreting the enhancement profiles are discussed. No significant differences in average signal enhancement or contrast agent concentration were observed between patients with different degrees of white matter abnormality, although there was a trend towards greater signal enhancement with more abnormal white matter. Furthermore, the results suggest that many of the factors considered introduce uncertainty of a similar magnitude to expected effect sizes, making it unclear whether differences in signal enhancement are truly reflective of an underlying BBB abnormality or due to an unrelated effect. As the ultimate aim is to achieve a reliable quantification of BBB function in subtle disorders, this study highlights the factors which may influence signal enhancement and suggests that further work is required to address the challenging problems of quantifying contrast agent concentration in healthy and diseased living human tissue and of establishing a suitable model to enable quantification of relevant physiological parameters. Meanwhile, it is essential that future studies use an appropriate control group to minimize these influences. Elsevier 2011-04 /pmc/articles/PMC4025605/ /pubmed/21030178 http://dx.doi.org/10.1016/j.mri.2010.09.002 Text en © 2010 Elsevier Inc. All rights reserved. https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/) .
spellingShingle Original Contribution
Armitage, Paul A.
Farrall, Andrew J.
Carpenter, Trevor K.
Doubal, Fergus N.
Wardlaw, Joanna M.
Use of dynamic contrast-enhanced MRI to measure subtle blood–brain barrier abnormalities()
title Use of dynamic contrast-enhanced MRI to measure subtle blood–brain barrier abnormalities()
title_full Use of dynamic contrast-enhanced MRI to measure subtle blood–brain barrier abnormalities()
title_fullStr Use of dynamic contrast-enhanced MRI to measure subtle blood–brain barrier abnormalities()
title_full_unstemmed Use of dynamic contrast-enhanced MRI to measure subtle blood–brain barrier abnormalities()
title_short Use of dynamic contrast-enhanced MRI to measure subtle blood–brain barrier abnormalities()
title_sort use of dynamic contrast-enhanced mri to measure subtle blood–brain barrier abnormalities()
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025605/
https://www.ncbi.nlm.nih.gov/pubmed/21030178
http://dx.doi.org/10.1016/j.mri.2010.09.002
work_keys_str_mv AT armitagepaula useofdynamiccontrastenhancedmritomeasuresubtlebloodbrainbarrierabnormalities
AT farrallandrewj useofdynamiccontrastenhancedmritomeasuresubtlebloodbrainbarrierabnormalities
AT carpentertrevork useofdynamiccontrastenhancedmritomeasuresubtlebloodbrainbarrierabnormalities
AT doubalfergusn useofdynamiccontrastenhancedmritomeasuresubtlebloodbrainbarrierabnormalities
AT wardlawjoannam useofdynamiccontrastenhancedmritomeasuresubtlebloodbrainbarrierabnormalities